Ellevest, Inc. Abb Vie Inc. Transaction History

Ellevest, Inc.

$1.8 Billion
Q3 2024

A detailed history of Ellevest, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ellevest, Inc. holds 2,694 shares of ABBV stock, worth $474,682. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,694

Previous 2,670 0.9%

Holding current value

$474,682

Previous $457,000 16.41%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $3,932 - $4,783	24 Added 0.9%	2,694 $532,000
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $64,547 - $75,376	417 Added 18.51%	2,670 $457,000
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $43,471 - $49,531	272 Added 13.73%	2,253 $410,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $15,411 - $17,356	112 Added 5.99%	1,981 $306,000
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $8,148 - $9,433	-61 Reduced 3.16%	1,869 $278,000
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $9,938 - $12,367	75 Added 4.04%	1,930 $260,000
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $2,892 - $3,330	20 Added 1.09%	1,855 $295,000
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $77,591 - $93,053	-561 Reduced 23.41%	1,835 $296,000
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $61,199 - $70,192	-456 Reduced 15.99%	2,396 $322,000
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $29,450 - $37,441	-214 Reduced 6.98%	2,852 $437,000
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $32,863 - $40,773	249 Added 8.84%	3,066 $497,000
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $42,542 - $53,828	-396 Reduced 12.32%	2,817 $381,000
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $65,116 - $73,917	612 Added 23.53%	3,213 $347,000
Q2 2021 Jul 13, 2021	SELL	$105.21 - $117.21 $56,497 - $62,941	-537 Reduced 17.11%	2,601 $293,000
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $3,069 - $3,378	30 Added 0.97%	3,138 $340,000
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $110,995 - $149,855	-1,379 Reduced 30.73%	3,108 $333,000
Q3 2020 Oct 26, 2020	SELL	$85.91 - $100.83 $40,291 - $47,289	-469 Reduced 9.46%	4,487 $393,000
Q2 2020 Jul 06, 2020	BUY	$73.37 - $98.18 $266,406 - $356,491	3,631 Added 274.04%	4,956 $487,000
Q1 2020 Apr 13, 2020	BUY	$64.5 - $97.79 $8,385 - $12,712	130 Added 10.88%	1,325 $101,000
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $53,231 - $66,604	738 Added 161.49%	1,195 $106,000
Q3 2019 Oct 08, 2019	BUY	$62.98 - $75.72 $1,574 - $1,893	25 Added 5.79%	457 $35,000
Q2 2019 Aug 20, 2019	SELL	$65.7 - $83.98 $3,482 - $4,450	-53 Reduced 10.93%	432 $31,000
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $17,665 - $20,790	229 Added 89.45%	485 $39,000
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $19,929 - $24,578	256 New	256 $24,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account